0591-0369
Generic: loxapine
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
loxapine
Labeler
actavis pharma, inc.
Dosage Form
CAPSULE
Active Ingredients
loxapine succinate 5 mg/1
Identifiers & Regulatory
Product NDC
0591-0369
Product ID
0591-0369_4218946e-199a-4814-bc2c-ba9088967631
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2027-12-31
Marketing Start
1988-06-15
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05910369
Hyphenated Format
0591-0369
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
loxapine (source: label)
Generic Name
loxapine (source: ndc)
Application Number
ANDA072204 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 5 mg/1
Packaging
- 80300 CAPSULE in 1 BAG (0591-0369-00)
- 5883 CAPSULE in 1 CONTAINER (0591-0369-77)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "4218946e-199a-4814-bc2c-ba9088967631", "openfda": {}, "finished": false, "packaging": [{"description": "80300 CAPSULE in 1 BAG (0591-0369-00)", "package_ndc": "0591-0369-00", "marketing_start_date": "15-JUN-88"}, {"description": "5883 CAPSULE in 1 CONTAINER (0591-0369-77)", "package_ndc": "0591-0369-77", "marketing_start_date": "23-JAN-26"}], "product_id": "0591-0369_4218946e-199a-4814-bc2c-ba9088967631", "dosage_form": "CAPSULE", "product_ndc": "0591-0369", "generic_name": "Loxapine", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "LOXAPINE SUCCINATE", "strength": "5 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "19880615", "listing_expiration_date": "20271231"}